These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 28940525)
1. Estimation of initial phenobarbital dosing in term neonates with moderate-to-severe hypoxic ischaemic encephalopathy following perinatal asphyxia. Šíma M; Pokorná P; Hartinger J; Slanař O J Clin Pharm Ther; 2018 Apr; 43(2):196-201. PubMed ID: 28940525 [TBL] [Abstract][Full Text] [Related]
2. Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia. Favié LMA; Groenendaal F; van den Broek MPH; Rademaker CMA; de Haan TR; van Straaten HLM; Dijk PH; van Heijst A; Simons SHP; Dijkman KP; Rijken M; Zonnenberg IA; Cools F; Zecic A; van der Lee JH; Nuytemans DHGM; van Bel F; Egberts TCG; Huitema ADR; Neonatology; 2019; 116(2):154-162. PubMed ID: 31256150 [TBL] [Abstract][Full Text] [Related]
3. Severity parameters for asphyxia or hypoxic-ischemic encephalopathy do not explain inter-individual variability in the pharmacokinetics of phenobarbital in newborns treated with therapeutic hypothermia. Pokorná P; Michaličková D; Völler S; Hronová K; Tibboel D; Slanař O; Krekels EH Minerva Pediatr (Torino); 2022 Apr; 74(2):107-115. PubMed ID: 33107271 [TBL] [Abstract][Full Text] [Related]
4. Effect of co-medication on the pharmacokinetic parameters of phenobarbital in asphyxiated newborns. Šíma M; Pokorná P; Hronová K; Slanař O Physiol Res; 2015; 64(Suppl 4):S513-9. PubMed ID: 26681081 [TBL] [Abstract][Full Text] [Related]
5. Severity of asphyxia is a covariate of phenobarbital clearance in newborns undergoing hypothermia. Pokorná P; Posch L; Šíma M; Klement P; Slanar O; van den Anker J; Tibboel D; Allegaert K J Matern Fetal Neonatal Med; 2019 Jul; 32(14):2302-2309. PubMed ID: 29357720 [TBL] [Abstract][Full Text] [Related]
6. Effect of high-dose phenobarbital on oxidative stress in perinatal asphyxia: an open label randomized controlled trial. Gathwala G; Marwah A; Gahlaut V; Marwah P Indian Pediatr; 2011 Aug; 48(8):613-7. PubMed ID: 21169640 [TBL] [Abstract][Full Text] [Related]
7. Phenobarbital pharmacokinetics in neonates and infants during extracorporeal membrane oxygenation. Pokorná P; Šíma M; Vobruba V; Tibboel D; Slanař O Perfusion; 2018 May; 33(1_suppl):80-86. PubMed ID: 29788839 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: an update. Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M J Clin Pharm Ther; 2011 Dec; 36(6):704-10. PubMed ID: 22023343 [TBL] [Abstract][Full Text] [Related]
9. Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy. Filippi L; la Marca G; Fiorini P; Poggi C; Cavallaro G; Malvagia S; Pellegrini-Giampietro DE; Guerrini R Epilepsia; 2009 Nov; 50(11):2355-61. PubMed ID: 19744111 [TBL] [Abstract][Full Text] [Related]
10. The influence of asphyxia on phenobarbital dosing requirements in neonates. Gal P; Toback J; Erkan NV; Boer HR Dev Pharmacol Ther; 1984; 7(3):145-52. PubMed ID: 6723489 [TBL] [Abstract][Full Text] [Related]
11. Phenobarbital for neonatal seizures in hypoxic ischemic encephalopathy: a pharmacokinetic study during whole body hypothermia. Filippi L; la Marca G; Cavallaro G; Fiorini P; Favelli F; Malvagia S; Donzelli G; Guerrini R Epilepsia; 2011 Apr; 52(4):794-801. PubMed ID: 21371018 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of phenobarbital in neonates with hypoxic ischemic encephalopathy. Singh D; Kumar P; Narang A J Matern Fetal Neonatal Med; 2005 Dec; 18(6):391-5. PubMed ID: 16390805 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach. van den Broek MP; Groenendaal F; Toet MC; van Straaten HL; van Hasselt JG; Huitema AD; de Vries LS; Egberts AC; Rademaker CM Clin Pharmacokinet; 2012 Oct; 51(10):671-9. PubMed ID: 23018530 [TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermia. Shellhaas RA; Ng CM; Dillon CH; Barks JD; Bhatt-Mehta V Pediatr Crit Care Med; 2013 Feb; 14(2):194-202. PubMed ID: 23254984 [TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia. Cies JJ; Fugarolas KN; Moore WS; Mason RW; Menkiti OR Pharmacotherapy; 2017 Apr; 37(4):456-463. PubMed ID: 28226400 [TBL] [Abstract][Full Text] [Related]
16. Developmental aspects of phenobarbital dosage requirements in newborn infants with seizures. Nahata MC; Masuoka T; Edwards RC J Perinatol; 1988; 8(4):318-20. PubMed ID: 3236100 [TBL] [Abstract][Full Text] [Related]
17. Phenobarbital dosing and pharmacokinetics in a neonate receiving extracorporeal membrane oxygenation. Elliott ES; Buck ML Ann Pharmacother; 1999 Apr; 33(4):419-22. PubMed ID: 10332532 [TBL] [Abstract][Full Text] [Related]